Inventor
ENG WAI-SI
US16 patents
⚠️ This page may combine multiple inventors who share the name “ENG WAI-SI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XW LAB INC
6 patentsUS10968202B2Apr 6, 2021
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
XW LAB INC38 citations98
US10730853B2Aug 4, 2020
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
XW LAB INC38 citations98
US10618886B1Apr 14, 2020
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
XW LAB INC38 citations98
US10836714B2Nov 17, 2020
Ketamine derivatives and compositions thereof
XW LAB INC41 citations97
US10683262B2Jun 16, 2020
Ketamine derivatives and compositions thereof
XW LAB INC40 citations97
US11149006B2Oct 19, 2021
Compounds as neurokinin-1 receptor antagonists and uses thereof
XW LAB INC0 citations62
XWPHARMA LTD
5 patentsUS12209060B2Jan 28, 2025
Ketamine derivatives and compositions thereof
XWPHARMA LTD1 citations74
US11420955B2Aug 23, 2022
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
XWPHARMA LTD2 citations73
US11440874B2Sep 13, 2022
Ketamine derivatives and compositions thereof
XWPHARMA LTD1 citations72
US12172980B2Dec 24, 2024
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
XWPHARMA LTD0 citations62
US11905247B2Feb 20, 2024
Compounds as neurokinin-1 receptor antagonists and uses thereof
XWPHARMA LTD0 citations62
MERCK & CO INC
3 patentsUS6060038AMay 9, 2000
Radiolabeled farnesyl-protein transferase inhibitors
MERCK & CO INC148 citations97
US5441722AAug 15, 1995
Short synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-[C3 H3 ]-4[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide and related non radioactive compounds
MERCK & CO INC14 citations72
US7354935B2Apr 8, 2008
Radiolabeled neurokinin-1 receptor antagonists
MERCK & CO INC2 citations60